Atorvastatin decreases lipoprotein(a): A meta-analysis of randomized trials

International Journal of Cardiology

Volumn 154, Issue 2, 2012, Pages 183-186

  Takagi, Hisato ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Atorvastatin; Lipoprotein(a); Meta analysis; Randomized trial

Indexed keywords

ATORVASTATIN; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; NICOTINIC ACID; PLACEBO; PRAVASTATIN; SIMVASTATIN;

ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; CONCENTRATION (PARAMETERS); DATA COLLECTION METHOD; DISEASE ASSOCIATION; DRUG MECHANISM; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROTEIN DEGRADATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR AFFINITY; RISK FACTOR; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STROKE;

EID: 84855849500     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.09.060     Document Type: Article

References (23)

1. B.G. Nordestgaard, M.J. Chapman, and K. Ray Lipoprotein(a) as a cardiovascular risk factor: current status Eur Heart J 31 2010 2844 2853
2. A. Bennet, E. Di Angelantonio, and S. Erqou Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data Arch Intern Med 168 2008 598 608 (Pubitemid 351468395)
3. E. Bruckert, J. Labreuche, and P. Amarenco Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis Atherosclerosis 210 2010 353 361
4. S. van Wissen, T.J. Smilde, M.D. Trip, T. de Boo, J.J. Kastelein, and A.F. Stalenhoef Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia Heart 89 2003 893 896 (Pubitemid 36920815)
5. S. Gonbert, S. Malinsky, and A.C. Sposito Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk Atherosclerosis 164 2002 305 311 (Pubitemid 35223081)
6. C. Hernández, G. Francisco, and A. Ciudin Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trial Diabetes Metab 37 2011 124 130
7. M.S. Joy, K.A. Dornbrook-Lavender, H. Chin, S.L. Hogan, and C. Denu-Ciocca Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients Ann Pharmacother 42 2008 9 15
8. Higgins JP, Deeks JJ, editors. Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
9. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
10. V.G. Athyros, A.A. Papageorgiou, V.V. Athyrou, D.S. Demitriadis, and A.G. Kontopoulos Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia Diabetes Care 25 2002 1198 1202 (Pubitemid 41071172)
11. B. Ky, A. Burke, and S. Tsimikas The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans J Am Coll Cardiol 51 2008 1653 1662 (Pubitemid 351626406)
12. S. Tsimikas, J.L. Witztum, and E.R. Miller High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial Circulation 110 2004 1406 1412 (Pubitemid 39238018)
13. M. Mishra, P. Durrington, and M. Mackness The effect of atorvastatin on serum lipoproteins in acromegaly Clin Endocrinol (Oxf) 62 2005 650 655 (Pubitemid 40825932)
14. E.J. Schaefer, J.R. McNamara, and T. Tayler Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects Am J Cardiol 90 2002 689 696 (Pubitemid 35279386)
15. W. Insull Jr. , J.N. Basile, A.N. Vo, P. Jiang, R. Thakkar, and R.J. Padley Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study J Clin Lipidol 3 2009 109 118
16. E.T. Bairaktari, C.S. Tzallas, V.K. Tsimihodimos, E.N. Liberopoulos, G.A. Miltiadous, and M.S. Elisaf Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia J Cardiovasc Risk 6 1999 113 116 (Pubitemid 29298071)
17. F. Krempler, G.M. Kostner, A. Roscher, F. Haslauer, K. Bolzano, and F. Sandhofer Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man J Clin Invest 71 1983 1431 1441 (Pubitemid 13098933)
18. D.J. Rader, W.A. Mann, and W. Cain The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans J Clin Invest 95 1995 1403 1408
19. G.M. Kostner, D. Gavish, B. Leopold, K. Bolzano, M.S. Weintraub, and J.L. Breslow HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels Circulation 80 1989 1313 1319 (Pubitemid 19282521)
20. C. Hernández, P. Chacón, L. García-Pascual, and R. Simó Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients Diabetes Care 24 2001 350 355 (Pubitemid 32119137)
21. A. Noma, A. Abe, and S. Maeda Lp(a): an acute-phase reactant? Chem Phys Lipids 67-68 1994 411 417 (Pubitemid 24054502)
22. D.P. Wade, J.G. Clarke, and G.E. Lindahl 5′ control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family Proc Natl Acad Sci U S A 90 1993 1369 1373 (Pubitemid 23058173)
23. J. Wang, B. Hu, L. Kong, H. Cai, and C. Zhang Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: plasma concentrations and relationship to inflammation Clin Chim Acta 390 2008 67 71